Overview

Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

Herpes labialis is the most common recurrent manifestation of herpes simplex. The purpose of this study is to check the non-inferiority efficacy and safety of penciclovir 10mg/g as treatment for Herpes Labialis in comparison to acyclovir 50mg/g.

Phase:

Phase 3

Details

Lead Sponsor:

EMS

Treatments:

Acyclovir
Penciclovir